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Summary
Background:  Embedding  dialysis  surveillance  scheme  is  associated  with  reductions
in  blood  stream  infection  and  antimicrobial  consumption  .The  aim  of  this  study
was  to  establish  baseline  dialysis  events  (DE)  rates;  hospitalization,  intravenous  (IV)
antibiotics  start  or  a  positive  blood  culture  stratiﬁed  by  vascular  access  category
and  comparisons  to  published  National  Healthcare  Safety  Network  (NHSN)  rates.
Methods:  A  retrospective  review  of  DE  was  done  between  January  to  December
2012,  in  ﬁve  outpatient  adult  hemodialysis  center.
Results:  The  pooled  mean  rates  of  hospitalization  among  patients  with  ﬁstulas,
grafts,  permanent  and  temporary  catheters  were  2.8,  5.7,  5.1,  and  10.6  per  100
patient-months,  respectively.  For  positive  blood  culture  the  pooled  mean  rates  were
0.2,  1.0,  1.9  and  2.7  per  100  patient-months  in  these  groups.  The  IV  antibiotics  starts
event  pooled  mean  rates  were  5.9,  9.0,  11.8,  and  11.2  per  100  patient-months.
DE  were  signiﬁcantly  more  common  in  patients  with  permanent  and  temporary
catheters  when  compared  with  patients  with  ﬁstulas  and  graft  (p  <  0.001).
Conclusion:  Surveillance  of  DE  rates  in  Kuwait  revealed  signiﬁcantly  lower  mean
rate  of  hospitalization  and  positive  blood  culture  while  IV  antimicrobial  start  shows
signiﬁcantly  higher  mean  rate  when  compared  to  published  NHSN  data.
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Ltd.  All  rights  reserved.
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ntroduction
emodialysis  (HD)  patients  are  uniquely  vulnera-
le to  the  development  of  healthcare-associated
nfections  because  of  multiple  factors,  including
xposure to  invasive  devices,  immunosuppression,
he lack  of  physical  barriers  between  patients  in  the
utpatient  hemodialysis  environment,  and  frequent
ontact  with  healthcare  workers  during  proce-
ures and  care  [1]. Four  types  of  vascular  access
re used  for  hemodialysis:  arteriovenous  (AV)  ﬁs-
ula, AV  graft,  tunneled  central  venous  access  and
emporary  venous  access.  Vascular  access-related
nfection is  a  known  complication  of  hemodialysis.
V ﬁstula  is  considered  to  be  the  most  favorable  in
erms of  function,  duration  and  absence  of compli-
ations [2].  Studies  have  shown  that  vascular  access
s one  of  the  most  important  risk  factors  for  infec-
ion and  bacteremia  in  hemodialysis  patients  [3].
The Dialysis  Outcome  Quality  Initiative  Guide-
ines (DOQI)  published  by  the  National  Kidney
oundation has  provided  a  list  of  techniques  that
ould be  applied  to  monitor  and  survey  vascular
ccess [4].  In  2008,  the  Center  for  Medicare  and
edicaid  Services  (CMS)  mandated  that  both  moni-
oring  and  surveillance  be  part  of  the  dialysis  care
eing provided  to  ESRD  patients  with  an  aim  of
dentifying  and  intervening  at  an  early  stage,  as
ell as  controlling  the  spiraling  costs  of  access  care
5].
The aim  of  this  study  was  to  establish  base-
ine dialysis  events  (DE)  rates,  i.e.,  hospitalization,
ntravenous (IV)  antibiotics  starts  or  a  posi-
ive blood  culture,  stratify  these  events  by  the
ascular access  category  and  compare  them  to  pub-
ished National  Healthcare  Safety  Network  (NHSN)
ates.
ethods
 retrospective  study  for  DE  surveillance  was
erformed for  all  maintenance  hemodialysis  outpa-
ients, including  transient  patients,  from  January
012 through  December  2012  in  ﬁve  adult  out-
atient hemodialysis  centers  from  ﬁve  health
egion (Al  Sabah-Al  Ahmadi-Al  Jahra-Hawaly-Al  Far-
anyia); these  centers  may  be  attached  to  or
fﬁliated  with  a  hospital.
All  data  were  derived  from  the  Kuwait  National
ealthcare-associated  Infections  Surveillance
ystem-Dialysis  events  (KNHSS-DE)  module,  which
s based  on  the  NHSN  Patient  Safety  Component
anual, Centers  for  Disease  Control  and  Prevention
CDC) in  of  the  United  States  Centers  for  Disease
ontrol and  Prevention.  A  DE  was  deﬁned  as  any
t
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atient  who  required  hospitalization,  had  an  IV
ntimicrobial  start  or  a positive  blood  culture.
ospitalizations  included  all  hospitalizations  that
nvolved an  overnight  stay,  irrespective  of how  soon
fter a  previous  hospitalization  the  stay  occurred.
he IV  antimicrobial  starts  included  all  outpatient
V antimicrobial  starts  or  outpatient  starts  that
ere continuations  of  inpatient  treatment  for  any
eason and  duration  of  treatment,  not  only  vascular
ccess  problems.  If  IV  antimicrobials  were  stopped
or ≤21  days,  the  treatment  was  considered  to  be
ame event.  Positive  blood  cultures  were  recorded
or all  positive  blood  specimens  drawn  from  a
eripheral  site  before  administering  antibiotics
ver one  24-h  period  on  an  outpatient  basis  or
ithin 1  day  of  hospital  admission,  irrespective
f whether  the  patient  received  treatment.  If
ositive  blood  cultures  occurred  less  than  21  days
part, the  second  positive  blood  culture(s)  was
ot considered  a new  dialysis  event,  and  new
rganisms from  these  subsequent  positive  blood
ultures  were  added  to  the  ﬁrst  report  [6].
Local access  infection,  access  associated  bac-
eremia  and  vascular  access  infections  were  deﬁned
s outlined  in  the  NHSN  protocol  [6].
The data  were  collected  as  a census  (denom-
nator), expressed  as  patient-months  and  events
numerators)  and  inputted  into  a  Microsoft  Excel
atabase.  The  DE  rates  were  stratiﬁed  by  vascular
ccess  type  and  expressed  per  100  patient-months.
he rates  were  calculated  by  dividing  the  number  of
vents by  the  number  of  patient-months  and  multi-
lying the  result  by  100.  Statistical  signiﬁcance  was
etermined  using  the  chi-square  test.  A  p  value  of
0.05 was  considered  statistically  signiﬁcant.
esults
f  the  patients  receiving  hemodialysis  at  these
ve centers,  79.4%  of  patients  were  Kuwaiti  citi-
ens. Sex  distribution  was  40.4%  male  (mean  age,
5.7 ±  14.6  years),  and  59.6%  female  (mean  age,
9.7 ±  14.9  years),  Overall,  the  age  ranged  from  19
o 92  with  a  mean  of  58.1  ±  14.9  years.
During the  12-month  study  period,  a total  of
364 dialysis  events  and  9487  patient  months  were
eported: the  DE  of  hospitalizations,  IV antibiotic
tarts and  positive  blood  cultures  were  observed  at
ates of  4.3,  9.0  and  1.1  per  100  patient-months,
espectively  (Fig.  1).
The analyses  of  DE,  local  access  site  infec-ion, vascular  access  infection  and  access-related
loodstream  infection  involved  comparisons  to  the
ublished  NHSN  [6]  by  means  of  incidence  rate
atios,  which  are  outlined  in  Table  1.
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Table  1  Distribution  of  dialysis  event  rates,  local  access  site  infection,  vascular  access  infection,  and  access-related  bloodstream  infection  by  vascular  access
category  and  comparisons  with  NHSN  rate.
KNHSS-DE  KNHSS  pat-months KNHSS-DE  rate NHSN-DE  NHSN  pat-months NHSN-DE  rate Incidence  density
p-value
Incidence  density
percentilea
Hospitalizationb
Total 410  9487  4.3 2985  27,881  10.7
AV  ﬁstula 121  4278  2.8 932  12,104  7.7  <0.001  17.5  (10—25)
AV  graft 30  523  5.7  632  6870  9.2  0.0131  37.5  (25—50)
Perm.  CL  224  4355  5.1  1380  8790  15.7  <0.001  17.5  (10—25)
Temp.  CL  35  331  10.6  41  118  34.7  <0.001  —
In-unit  IV  antimicrobial  start
Total 852  9487  9.0 977  27,865  3.5
AV  ﬁstula 253  4278  5.9 218  12,111  1.8 <0.001  >90%
AV  graft 47  523  9.0 163  6792  2.4  <0.001  >90%
Perm.  CL 515  4355  11.8  566  8844  6.4  <0.001  82.5  (75—90)
Temp.  CL  37  331  11.2  30  118  25.4  0.0017  —
In-unit  IV  vancomycin  start
Total  202  9487  2.1  716  28,234  2.5
AV  ﬁstula  27  4278  0.6  148  12,333  1.2  0.0018  37.5  (25—50)
AV  graft  5  523  1.0  113  7063  1.6  0.2481  37.5  (25—50)
Perm.  CL  151  4355  3.5  436  8720  5  <0.001  62.5  (50—75)
Temp.  CL  19  331  5.7  19  118  16.1  <0.001  —
Positive  blood  culture
Total  102  9487  1.1  532  28,623  1.9
AV  ﬁstula  7  4278  0.2  63  12,600  0.5  0.0031  37.5  (25—50)
AV  graft  5  523  1.0  63  7000  0.9  0.8971  62.5  (50—75)
Perm.  CL  81  4355  1.9  374  8905  4.2  <0.001  37.5  (25—50)
Temp.  CL  9  331  2.7  32  118  27.1  <0.001  —
Local  access  infection
Total  137  9487  1.4  212  30,074  0.7
AV  ﬁstula  17  4278  0.4  27  13,500  0.2  0.0239  82.5  (75—90)
AV  graft  3  523  0.6  31  7750  0.4  0.5499  82.5  (75—90)
Perm.  CL  103  4355  2.4  148  8706  1.7  0.0105  82.5  (75—90)
Temp.  CL  14  331  4.2  6  118  5.1  0.7120  —
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Digure  1  Rate  of  DE  per  100  patient-months  in  KNHSS
nd  NHSN.
The  pooled  mean  rates  of  hospitalization  events
mong patients  with  AV  ﬁstulas,  grafts,  perma-
ent and  temporary  catheters  were  2.8,  5.7,  5.1,
nd 10.6  per  100  patient-months,  respectively.  For
ositive blood  culture  events,  the  pooled  mean
ates were  0.2,  1.0,  1.9  and  2.7  per  100  patient-
onths in  these  groups,  while  the  event  pooled
ean rates  for  IV  antibiotics  starts  were  5.9,  9.0,
1.8, and  11.2  per  100  patient-months;  of  these
vents,  vancomycin  was  used  in  23.7%  of cases
202/852).
The events  varied  substantially  by  vascular
ccess type,  and  the  DE  were  signiﬁcantly  more
ommon in  patients  with  permanent  and  temporary
V catheters  compared  to  patients  with  ﬁstulas  and
raft (p  <  0.001).
Table  2  shows  that  107  isolates  were  reported
rom 102  positive  blood  cultures.  Of  these,  93
87%) represented  access-associated  bloodstream
nfections in  patients  with  permanent  or  tempo-
ary central  lines,  and  14  (13%)  were  in  patients
ith ﬁstulas  or  grafts.  Among  the  isolates  from
atients with  all  vascular  access,  the  microor-
anisms most  frequently  identiﬁed  were  common
kin contaminants  40.2%.  Staphylococcus  aureus
as isolated  in  12.1%  of  cases  (13  of  107)  of
hich 30.7%  (4  of  13)  were  resistant  to  methi-
illin (MRSA).  Of  the  remaining  cases,  13.1%  (14  of
07) were  gram-positive  bacilli,  31.8%  (34  of  107)
ere gram-negative  bacilli,  and  2.8%  were  classi-
ed as  fungi  and  not  further  characterized.  None
f the  Enterococci  in  this  study  were  found  to  be
ancomycin-resistant.iscussion
hese  initial  results  were  obtained  using  the  KNHSS-
E module,  the  ﬁrst  national  system  for  monitoring
390  D.A.  Badawy  et  al.
Table  2  Microorganisms  isolated  from  blood  cultures  from  access-related  bacteremias  reported  to  dialysis  surveil-
lance,  January  2012  through  December  2012.
Access-associated  blood
stream  infection  number  (%)
(permanent  or  temporary)
Access-associated  blood
stream  infection  number  (%)
(ﬁstula  or  graft)
Total  (%)
Staphylococcus  aureus 10  (10.7)  3  (21.4)  13  (12.1)
VREa 0  0  0
Other  gram-positive 14  (15.1) 0  14  (13.1)
Gram-negative  rods 30  (32.2) 4  (28.5) 34  (31.8%)
Common  skin  contaminantsb 36  (38.8) 7  43  (40.2)
Fungi  3  (3.2) 0  3  (2.8%)
Other  0  0  0
Total  93  (87%)  14  (13%)  107
a Vancomycin-resistant enterococci.
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ab Common skin contaminants included: coagulase-negative S
lococcus auricularis,  Staphylococcus haemolyticus, Staphyloco
infections  and  related  events  in  outpatients  under-
going hemodialysis.
While  comparisons  of  Kuwaiti  dialysis  centers
rates with  NHSN  rates  are  difﬁcult  because  of
potential differences  in  patient  case  mixes,  dialy-
sis care  provision  and  staff  performance  in  practice,
and  underlying  diseases,  it  does  represent  an  area
that necessitates  future  research.
The Centers  for  Medicare  and  Medicaid  Services
launched a  major  initiative  to  promote  ﬁstula  use
because of  their  lower  infection  rates,  and  this
effort is  critical  to  prevent  vascular  access  infec-
tions  in  hemodialysis  patients  [7].
In the  current  study,  the  rate  of  hospitalization
among  patients  with  central  lines  was  5.1  per  100
patient-months,  compared  with  2.8  and  5.7  per  100
patient-months  for  patients  with  AV  ﬁstulas  and  AV
grafts, respectively.  The  NHSN  described  a hospi-
talization  rate  of  15.7  per  100  patient-months  for
patients  with  permanent  catheters  compared  with
7.7 and  9.2  per  100  patient-months  for  patients
with AV  ﬁstulas  or  grafts,  respectively.  The  mean
rate of  hospitalization  in  patients  with  permanent
catheters for  all  of  KNHSS-DE  was  lower  than  for
NHSN (5.1  hospitalization  per  100  patient-months
versus 15.7  per  100  patient-months).  The  KNHSS-
DE represents  a  lower  outlier  (10—25  percentile)
when compared  with  the  NHSN  percentiles  with  a
p <  0.001.
A  hospitalization  event  for  any  reason  was  pre-
viously reported  as  a  DE,  and  this  practice  was
discontinued in  June  2011  [8].  Hospitalization  is
now reportable  as  an  outcome  of  a  DE.
Appropriate  antimicrobial  prescribing  is  essen-
tial to  limit  the  emergence  of  antimicrobial
resistant  organisms,  such  as  MRSA,  in  this  patient
population [6]. In  our  study,  the  rate  of  IV  antimi-
crobial starts  for  patients  with  permanent  catheters
i
1
r
oylococcus,  Diphtheroids, Staphylococcus epidermidis, Staphy-
hominis.
as  11.8  per  100  patient-months  compared  with  5.9
nd 9.0  per  100  patient-months  for  patients  with  AV
stulas and  AV  grafts,  respectively.
The NHSN  reported  IV  antimicrobial  start  rates  of
.4 per  100  patient-months  for  patients  with  per-
anent  catheters  compared  with  1.8  and  2.4  per
00 patient-months  for  patients  with  AV  ﬁstulas  or
rafts, respectively.  The  mean  rate  of  IV  antimi-
robial start  in  patients  with  permanent  catheters
or all  of  NHSN  was  lower  than  for  our  facilities
6.4 IV  antimicrobial  starts  per  100  patient-months
ersus 11.8  IV  antimicrobial  start  per  100  patient-
onths).  Our  data  represent  a high  outlier  (>90th
ercentile)  when  considered  in  the  context  of  NHSN
ercentiles,  with  a p  < 0.001.
The  rates  of  positive  blood  culture  in  patients
ndergoing hemodialysis  appear  to  vary  depending
n the  type  of  vascular  access  that  is  present  [6].
atients who  have  a permanent  catheter  are  at  a
igher risk  for  positive  blood  culture  than  those
ith other  forms  of  access.  In  the  present  study,  the
ositive blood  culture  rate  for  patients  with  per-
anent  catheters  was  1.9  per  100  patient-months
ompared with  0.2  and  1.0  per  100  patient-months
or patients  with  AV  ﬁstulas  and  AV  grafts,  respec-
ively.
The  NHSN  reported  positive  blood  culture  rates
f 4.2  per  100  patient-years  for  patients  with
atheters  compared  with  0.5  and  0.9  per  100
atient-months for  patients  with  AV  ﬁstulas  or
rafts, respectively.
The mean  rate  of  positive  blood  cultures  in
atients with  permanent  catheters  was  higher  for
ll of  NHSN  [6]  than  for  Kuwaiti  facilities  (4.2  pos-
tive blood  cultures  per  100  patient-months  versus
.9 positive  blood  culture  per  100  patient-months,
espectively).  Kuwaiti  facilities  ranked  in  25—50%
f all  facilities  reporting  to  NHSN  with  a p  <  0.001.
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Although  a  high  rate  or  ratio  (90th  percentile)
oes not  necessarily  deﬁne  a  problem,  it  does  sug-
est an  area  for  further  investigation.  Similarly,  a
ow rate  or  ratio  (10th  percentile)  may  be  the  result
f inadequate  infection  detection.
Methicillin-resistant  S.  aureus  is  a  major  prob-
em among  patients  undergoing  hemodialysis  in  the
nited States  [9]. In  the  KNHSS-DE,  30.7%  of  all  S.
ureus isolates  from  positive  blood  cultures  were
RSA compared  with  42%  of  all  S. aureus  isolates
rom dialysis  centers  participating  in  the  NHSN.
Among dialysis  centers  participating  in  the
NHSS-DE module,  the  most  frequently  reported
rganisms among  bloodstream  infections  in  patients
ith vascular  access  were  common  skin  contami-
ants. We  cannot  determine  whether  any  of  the
ommon  skin  contaminants  were  true  pathogens
r specimen  contamination  [10]. These  results  are
onsistent  with  the  published  NHSN  report  [6].
In conclusion,  the  surveillance  of  DE  rates  in
uwait revealed  a  signiﬁcantly  lower  mean  rate  of
ospitalization  and  positive  blood  cultures,  while
V antimicrobial  starts  showed  signiﬁcantly  higher
ean rates  than  those  published  in  the  NHSN  data.
ialysis centers  should  minimize  the  use  of  perma-
ent catheters  in  HD  patients  whenever  possible
nd provide  additional  staff  education  regarding
ntimicrobial stewardship  principles  and  aseptic
echniques.  These  results  represent  the  ﬁrst  report
n DE  from  a  Multi-facility  Hemodialysis  Center.
We recommend  continuing  surveillance  in  all
aintenance hemodialysis  outpatients  units  with  a
emi-annual review  of  the  results  to  provide  feed-
ack to  healthcare  personnel  and  identify  areas
or intervention  in  which  improvements  in  infection
ontrol might  be  needed.
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